| Name | Title | Contact Details |
|---|
Oramed Pharmaceuticals (Nasdaq/TASE: ORMP) is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery (POD™) technology. Oramed is seeking to transform the treatment of diabetes through its proprietary lead candidate, ORMD-0801, which is being evaluated in two pivotal Phase 3 studies and has the potential to be the first commercial oral insulin capsule for the treatment of diabetes. In addition, Oramed is developing an oral GLP-1 (Glucagon-like peptide-1) analog capsule (ORMD-0901).
Sunovion Pharmaceuticals Inc., known until October 12, 2010 as Sepracor, Inc.
Pharmasset, Inc. is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ortho Clinical Diagnostics is an in vitro diagnostics company that makes products and diagnostic equipment for blood testing.
MiddleBrook Pharmaceuticals, Inc. is a Westlake, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.